Company Profile
Mangalam Drugs & Organics Limited, together with its subsidiary manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers active pharmaceutical ingredients (API) products
Including acyclovir, amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, etodolac, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, olanzapine, primaquine and piperaquine phosphate, pyrimethamine, pyronaridine tetraphosphate, sulfadoxine, tenofovir alafenamide hemifumarate, and tenofovir disoproxil fumarate, as well as intermediates, such as 2-dibutylamino-1-(2,7-dichloro-9H-fluorine-4-yl)-ethanol.
Its portfolio also includes 4,6-dichloro-5-methoxy pyrimidine, 4,7 dichloroquinoline, ortho phenoxy methane sulfonanilide, tenofovir alafenamide base, and tenofovir disoproxil base.
Additionally, it offers specialty chemicals comprising l(+)menthol. Its portfolio also includes 2,3-dihydrophthalazine-1, 4-dione or phthalazine-1,4-dione, and 4-cynoethyl-2-methy phenol.
It also manufactures organic and inorganic chemicals, and heavy chemicals, as well as active pharmaceutical ingredients products covering various therapeutic areas comprising anti-malaria, anti-retroviral, anti-hypertensive, anti-inflammatory, anti-convulsant, anti-viral, anti-rheumatic arthritis agents, and anti-bacterial Develops product for anti-hypertensive indications. Mangalam Drugs & Organics Limited was incorporated in 1972 and is based in Mumbai, India.